OHSU Knight Cancer Institute: Breast Neoplasms trials

The registry lists 25 Breast Neoplasms studies with OHSU Knight Cancer Institute as lead sponsor. 3 are open to participants now and 4 have results posted.

Early Phase 1 2Phase 1 4Phase 2 5Phase 3 2No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• EMBRACE: Exercising TogetherRecruitingNCT06049355Phase 2
• MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and ReferralsEnrolling by invitationNCT04996316
• 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast CancerRecruitingNCT04529044Phase 2
• EXERCISING TOGETHER for Couples Coping With CancerCompletedNCT03630354Not applicableResults posted
• Therapy to Prevent Sexual Pain in Breast Cancer SurvivorsCompletedNCT01539317Phase 3Results posted
• Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone TherapyCompletedNCT01422408Phase 2Results posted
• Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor TherapyTerminatedNCT00722072Phase 2Results posted
• Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related SymptomsCompletedNCT05793957Not applicable
• ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian CancerWithdrawnNCT05368506Early Phase 1
• SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
• StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer PatientsWithdrawnNCT05073172Not applicable
• Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate CancerCompletedNCT05012813Not applicable
• Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE StudyActive, not recruitingNCT04993313Not applicable
• Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialTerminatedNCT03878524Phase 1
• Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast CancerCompletedNCT03544125Phase 1
• Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation TherapyCompletedNCT03135782Not applicable
• CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health CentersCompletedNCT02355262
• Blood Samples From Patients on a Clinical Trial to CINV During HSCTTerminatedNCT00900068
• Aerobic Exercise, Resistance Exercise, or Flexibility and Relaxation Training in Inactive Older Female Breast Cancer SurvivorsCompletedNCT00662103Not applicable
• Optimizing Body Composition & Health After Breast CancerCompletedNCT00659906Not applicable
• Strength Training for Older Breast Cancer SurvivorsCompletedNCT00591747Not applicable
• Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast CancerTerminatedNCT00516542Phase 1
• BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the BrainWithdrawnNCT00397501Phase 1/2
• Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantTerminatedNCT00324324Phase 3
• Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast CancerCompletedNCT00031811Not applicable